Cargando…
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
OBJECTIVES: Non-adherence to therapy is an important cause of suboptimal blood pressure control but few practical tools exist to accurately and routinely detect it. We used a simple urine-based assay to evaluate the prevalence of antihypertensive treatment non-adherence and its impact on blood press...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033175/ https://www.ncbi.nlm.nih.gov/pubmed/24694797 http://dx.doi.org/10.1136/heartjnl-2013-305063 |
_version_ | 1782317779780632576 |
---|---|
author | Tomaszewski, Maciej White, Christobelle Patel, Prashanth Masca, Nicholas Damani, Ravi Hepworth, Joanne Samani, Nilesh J Gupta, Pankaj Madira, Webster Stanley, Adrian Williams, Bryan |
author_facet | Tomaszewski, Maciej White, Christobelle Patel, Prashanth Masca, Nicholas Damani, Ravi Hepworth, Joanne Samani, Nilesh J Gupta, Pankaj Madira, Webster Stanley, Adrian Williams, Bryan |
author_sort | Tomaszewski, Maciej |
collection | PubMed |
description | OBJECTIVES: Non-adherence to therapy is an important cause of suboptimal blood pressure control but few practical tools exist to accurately and routinely detect it. We used a simple urine-based assay to evaluate the prevalence of antihypertensive treatment non-adherence and its impact on blood pressure in a specialist hypertension centre. METHODS: 208 hypertensive patients (125 new referrals, 66 follow-up patients with inadequate blood pressure control and 17 renal denervation referrals) underwent assessment of antihypertensive drug intake using high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis at the time of clinical appointment. A total of 40 most commonly prescribed antihypertensive medications (or their metabolites) were screened for in spot urine samples. RESULTS: Overall, 25% of patients were totally or partially non-adherent to antihypertensive treatment (total non-adherence 10.1%, partial non-adherence 14.9%). The highest prevalence of partial and total non-adherence was among follow-up patients with inadequate blood pressure control (28.8%) and those referred for consideration of renal denervation (23.5%), respectively. There was a linear relationship between blood pressure and the numerical difference in detected/prescribed antihypertensive medications—every unit increase in this difference was associated with 3.0 (1.1) mm Hg, 3.1 (0.7) mm Hg and 1.9 (0.7) mm Hg increase in adjusted clinic systolic blood pressure, clinic diastolic blood pressure (DBP) and 24 h mean daytime DBP (p=0.0051, p=8.62×10(−6), p=0.0057), respectively. CONCLUSIONS: Non-adherence to blood pressure lowering therapy is common, particularly in patients with suboptimal blood pressure control and those referred for renal denervation. HP LC-MS/MS urine analysis could be used to exclude non-adherence and better stratify further investigations and intervention. |
format | Online Article Text |
id | pubmed-4033175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-40331752014-06-05 High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis Tomaszewski, Maciej White, Christobelle Patel, Prashanth Masca, Nicholas Damani, Ravi Hepworth, Joanne Samani, Nilesh J Gupta, Pankaj Madira, Webster Stanley, Adrian Williams, Bryan Heart Cardiac Risk Factors and Prevention OBJECTIVES: Non-adherence to therapy is an important cause of suboptimal blood pressure control but few practical tools exist to accurately and routinely detect it. We used a simple urine-based assay to evaluate the prevalence of antihypertensive treatment non-adherence and its impact on blood pressure in a specialist hypertension centre. METHODS: 208 hypertensive patients (125 new referrals, 66 follow-up patients with inadequate blood pressure control and 17 renal denervation referrals) underwent assessment of antihypertensive drug intake using high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis at the time of clinical appointment. A total of 40 most commonly prescribed antihypertensive medications (or their metabolites) were screened for in spot urine samples. RESULTS: Overall, 25% of patients were totally or partially non-adherent to antihypertensive treatment (total non-adherence 10.1%, partial non-adherence 14.9%). The highest prevalence of partial and total non-adherence was among follow-up patients with inadequate blood pressure control (28.8%) and those referred for consideration of renal denervation (23.5%), respectively. There was a linear relationship between blood pressure and the numerical difference in detected/prescribed antihypertensive medications—every unit increase in this difference was associated with 3.0 (1.1) mm Hg, 3.1 (0.7) mm Hg and 1.9 (0.7) mm Hg increase in adjusted clinic systolic blood pressure, clinic diastolic blood pressure (DBP) and 24 h mean daytime DBP (p=0.0051, p=8.62×10(−6), p=0.0057), respectively. CONCLUSIONS: Non-adherence to blood pressure lowering therapy is common, particularly in patients with suboptimal blood pressure control and those referred for renal denervation. HP LC-MS/MS urine analysis could be used to exclude non-adherence and better stratify further investigations and intervention. BMJ Publishing Group 2014-06-01 2014-04-03 /pmc/articles/PMC4033175/ /pubmed/24694797 http://dx.doi.org/10.1136/heartjnl-2013-305063 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Cardiac Risk Factors and Prevention Tomaszewski, Maciej White, Christobelle Patel, Prashanth Masca, Nicholas Damani, Ravi Hepworth, Joanne Samani, Nilesh J Gupta, Pankaj Madira, Webster Stanley, Adrian Williams, Bryan High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis |
title | High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis |
title_full | High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis |
title_fullStr | High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis |
title_full_unstemmed | High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis |
title_short | High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis |
title_sort | high rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (hp lc-ms/ms) urine analysis |
topic | Cardiac Risk Factors and Prevention |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033175/ https://www.ncbi.nlm.nih.gov/pubmed/24694797 http://dx.doi.org/10.1136/heartjnl-2013-305063 |
work_keys_str_mv | AT tomaszewskimaciej highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis AT whitechristobelle highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis AT patelprashanth highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis AT mascanicholas highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis AT damaniravi highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis AT hepworthjoanne highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis AT samaninileshj highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis AT guptapankaj highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis AT madirawebster highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis AT stanleyadrian highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis AT williamsbryan highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis |